Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Technology
E-089-2002
Patent ID
E-089-2002-1-US-47
Country
US
Application Type
REISSUE
Patent Status
Issued
Patent Number
46631
Publication Number
 
Application Number
13/896,384
IC
NIAID
Date Filed
Date Issued